Navidea Biopharmaceuticals, Inc. Navidea Biopharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Careers
  • Technology
    • Overview
    • Grant Funding
  • Pipeline
  • News & Media
    • Press Releases
    • Events
    • Publications
    • In the News
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • Events
  • Publications
  • In the News

Navidea Biopharmaceuticals Appoints Dr. Michael Rosol as Chief Medical Officer

Nov 29, 2018

Navidea Biopharmaceuticals to Present at the 11th Annual LD Micro Event 2018

Nov 28, 2018

Navidea Biopharmaceuticals Announces Presentation at the Radiological Society of North America (RSNA) 104th Scientific Assembly and Annual Meeting 2018

Nov 27, 2018

Navidea Biopharmaceuticals Appoints Dr. Kathy Rouan to Board of Directors

Nov 26, 2018

Navidea Biopharmaceuticals Reports Third Quarter 2018 Financial Results

Nov 7, 2018

Navidea Biopharmaceuticals Schedules Third Quarter 2018 Earnings Conference Call and Business Update

Nov 1, 2018

Navidea Biopharmaceuticals Wins Dismissal of Platinum Litigation

Oct 31, 2018

Navidea Biopharmaceuticals Receives Acceptance Letter from NYSE American

Oct 30, 2018

Navidea Biopharmaceuticals to Present Data on the Manocept Platform at 2018 ACR Annual Meeting

Oct 11, 2018

Navidea Biopharmaceuticals to Present at the 2018 BIO Investor Forum

Oct 8, 2018
    • 1...
    • 11
    • 12
    • 13
    • 14
    • 15
    • 16
    • 17
    • 18
    • 19
    • 20
    • ...45
    © 2025 Navidea Biopharmaceuticals, Inc. All Rights Reserved.
    linkedin
    Privacy Policy Disclaimer Sitemap